B. Fijal

发表

The association of single nucleotide polymorphisms in the catechol-O-methyltransferase gene and pain scores in female patients with major depressive disorder.

R. Perlis, A. Heinloth, B. Fijal, 2010, The journal of pain : official journal of the American Pain Society.

A common promoter polymorphism in the hepatic lipase gene (LIPC-480C>T) is associated with an increase in coronary calcification in type 1 diabetes.

J. Hokanson, M. Rewers, R. Eckel, 2002, Diabetes.

A phase 2, placebo-controlled study of the opioid receptor antagonist LY2196044 for the treatment of alcohol dependence.

R. Dean, K. Schuh, R. Anton, 2014, Alcoholism, clinical and experimental research.

Genetic associations of prolactin increase in olanzapine/fluoxetine combination-treated patients

A. Heinloth, B. Fijal, J. Houston, 2010, Psychiatry Research.

Lifetime prevalence of uveal melanoma in white patients with oculo(dermal) melanocytosis.

R. Elston, C. Shields, Arun D. Singh, 1998, Ophthalmology.

Case-control study of the association between select HLA genes and anti-erythropoietin antibody-positive pure red-cell aplasia.

D. Fife, Xiaodong Wu, Nadine Cohen, 2008, Pharmacogenomics.

Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia

S. Kapur, R. Conley, J. Kane, 2009, The Pharmacogenomics Journal.

Clinical trials in the genomic era: effects of protective genotypes on sample size and duration of trial.

J. Witte, J. M. Hall, B. Fijal, 2000, Controlled clinical trials.

Lipoprotein Lipase Gene Polymorphisms in Croatian Patients with Coronary Artery Disease

Suzanne Cheng, B. Gršković, B. Fijal, 2003, Clinical chemistry and laboratory medicine.

Familial uveal melanoma, III. Is the occurrence of familial uveal melanoma coincidental?.

Ashutosh Kumar Singh, R. Elston, C. Shields, 1996, Archives of ophthalmology.

The influence of lipoprotein lipase gene polymorphisms on coronary artery disease and plasma lipids in Zagreb cohort

Suzanne Cheng, B. Gršković, B. Fijal, 2003 .

Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophrenia.

R. Conley, J. Bishop, Jared R Kohler, 2012, The Journal of clinical psychiatry.

P4-161 Impact of APOE genotype on the efficacy of galantamine for the treatment of mild cognitive impairment

M. Gold, B. Fijal, J. Nye, 2004, Neurobiology of Aging.

Analysis of mutational spectra: locating hotspots and clusters of mutations using recursive segmentation

J. Witte, R. M. Idury, B. Fijal, 2002, Statistics in medicine.

Variation in Catechol-O-Methyltransferase Is Associated with Duloxetine Response in a Clinical Trial for Major Depressive Disorder

M. Trivedi, R. Perlis, B. Fijal, 2009, Biological Psychiatry.

Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration.

R. Klein, R. Elston, Kristine E. Lee, 2004, American journal of human genetics.

The Genetic Epidemiology of Age-Related Maculopathy

R. Klein, R. Elston, B. Klein, 2001 .

A whole-genome screen of a quantitative trait of age-related maculopathy in sibships from the Beaver Dam Eye Study.

R. Klein, R. Elston, S. Tomany, 2003, American journal of human genetics.

Association between CYP2D6 genotype and tardive dyskinesia in Korean schizophrenics

W. Koch, D. Flockhart, J. Shin, 2002, The Pharmacogenomics Journal.

Evaluation of genetic models for response in a randomized clinical trial of duloxetine in major depressive disorder

A. Heinloth, B. Fijal, J. Houston, 2012, Psychiatry Research.

Association of DRD2 and ANKK1 polymorphisms with prolactin increase in olanzapine-treated women

J. Bishop, B. Fijal, J. Houston, 2011, Psychiatry Research.

Failure to Replicate Genetic Associations with Antidepressant Treatment Response in Duloxetine-Treated Patients

R. Perlis, A. Heinloth, B. Fijal, 2010, Biological Psychiatry.

Genetic association study of treatment response with olanzapine/fluoxetine combination or lamotrigine in bipolar I depression.

R. Perlis, M. Farmen, A. Breier, 2010, The Journal of clinical psychiatry.

Gain and loss of function of P2X7 receptors: mechanisms, pharmacology and relevance to diabetic neuropathic pain

L. Munsie, Y. Qian, E. Sher, 2014, Molecular pain.

Analysis of gene variants previously associated with iloperidone response in patients with schizophrenia who are treated with risperidone.

R. Conley, M. Witte, B. Kinon, 2012, The Journal of clinical psychiatry.

Designing pharmacogenetic projects in industry: practical design perspectives from the Industry Pharmacogenomics Working Group

C M Bromley, S Close, N Cohen, 2009, The Pharmacogenomics Journal.

CYP2D6 predicted metabolizer status and safety in adult patients with attention‐deficit hyperactivity disorder participating in a large placebo‐controlled atomoxetine maintenance of response clinical trial

L. Nisenbaum, H. Upadhyaya, B. Fijal, 2015, Journal of clinical pharmacology.

Pharmacogenetic investigation of response to duloxetine treatment in generalized anxiety disorder

R. Perlis, B. Fijal, J. Houston, 2012, The Pharmacogenomics Journal.

Introduction: Analysis of Sequence Data and Population Structure

J S Witte, B A Fijal, J. Witte, 2001, Genetic epidemiology.

Evaluating the performance of a genetic test using information from previous studies in place of a gold standard.

J S Witte, B A Fijal, J. Witte, 1998, Medical care.

Association of common variations in the norepinephrine transporter gene with response to olanzapine-fluoxetine combination versus continued-fluoxetine treatment in patients with treatment-resistant depression: a candidate gene analysis.

R. Perlis, A. Heinloth, B. Fijal, 2012, The Journal of clinical psychiatry.

Genetic associations of prolactin increase in olanzapine/fluoxetine combination-treated patients

A. Heinloth, B. Fijal, J. Houston, 2010, Psychiatry Research.